Get startedLog in
    Picture of Genscript Biotech logo

    1548 — Genscript Biotech News Story

    0.000.00%
    hk flag iconLast trade - 00:00
    HealthcareHighly SpeculativeLarge CapNeutral
    All News

    Brief: Genscript Biotech Says Exclusive Global Licensing Deal Between Legend And Novartis Closed

    Picture of Genscript Biotech logoGenscript Biotech
    03/01/2024 15:09
    Jan 3 (Reuters) - Genscript Biotech Corp  1548.HK :
    * CLOSING OF EXCLUSIVE GLOBAL LICENSING AGREEMENT BETWEEN
LEGEND
BIOTECH AND NOVARTIS
    * LEGEND CLOSED LICENSE AGREEMENT WITH NOVARTIS FOR CERTAIN
LEGEND
CHIMERIC ANTIGEN RECEPTOR T-CELL CELL THERAPIES
    * AGREEMENT WITH NOVARTIS FOR CERTAIN LEGEND CHIMERIC
ANTIGEN
RECEPTOR T-CELL CELL THERAPIES TARGETING DELTA-LIKE LIGAND
PROTEIN 3

Further company coverage:  1548.HK 

 ((Reuters.Briefs@thomsonreuters.com;))

    Recent news on Genscript Biotech

    See all news